Cargando…
Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US
The severe respiratory illness due to SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19), is triggered by an intense pro-inflammatory host response. Statins, prescribed primarily for lipid reduction, are known to have anti-inflammatory and immunomodulatory properties and have...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887302/ https://www.ncbi.nlm.nih.gov/pubmed/33614688 http://dx.doi.org/10.3389/fmed.2021.639804 |
_version_ | 1783651952574332928 |
---|---|
author | Marić, Ivana Oskotsky, Tomiko Kosti, Idit Le, Brian Wong, Ronald J. Shaw, Gary M. Sirota, Marina Stevenson, David K. |
author_facet | Marić, Ivana Oskotsky, Tomiko Kosti, Idit Le, Brian Wong, Ronald J. Shaw, Gary M. Sirota, Marina Stevenson, David K. |
author_sort | Marić, Ivana |
collection | PubMed |
description | The severe respiratory illness due to SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19), is triggered by an intense pro-inflammatory host response. Statins, prescribed primarily for lipid reduction, are known to have anti-inflammatory and immunomodulatory properties and have been associated with a reduced mortality rate among COVID-19 patients taking statins as reported in two recent retrospective studies. However, a meta-analysis that included nine studies showed that statin use did not improve in-hospital outcomes of those with COVID-19. In addition, concerns regarding the use of statins and an increase in COVID-19 infections have been raised, as statins may increase the expression of angiotensin-converting enzyme 2 (ACE2), the primary receptor for the SARS-CoV-2 virus. Our goal was to investigate the effect of statins in COVID-19 patients in a large, diverse patient population across the United States containing nearly 120,000 patients diagnosed with COVID-19. We used propensity score matching of demographics, comorbidities, and medication indication to compare statin-treated patients (N = 2,297) with matched controls (N = 4,594). We observed a small, but statistically significant, decrease in mortality among patients prescribed statins (16.1%) when compared with matched COVID-19-positive controls (18.0 to 20.6%). These results support previous evidence that statins do not increase COVID-19-related mortality and may, in fact, have a mitigating effect on severity of the disease reflected in a slight reduction in mortality. Mixed findings on effects of statins in COVID-19 patients reported in the literature should prompt prospective randomized controlled trials in order to define better who might be advantaged with respect to clinical outcomes. |
format | Online Article Text |
id | pubmed-7887302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78873022021-02-18 Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US Marić, Ivana Oskotsky, Tomiko Kosti, Idit Le, Brian Wong, Ronald J. Shaw, Gary M. Sirota, Marina Stevenson, David K. Front Med (Lausanne) Medicine The severe respiratory illness due to SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19), is triggered by an intense pro-inflammatory host response. Statins, prescribed primarily for lipid reduction, are known to have anti-inflammatory and immunomodulatory properties and have been associated with a reduced mortality rate among COVID-19 patients taking statins as reported in two recent retrospective studies. However, a meta-analysis that included nine studies showed that statin use did not improve in-hospital outcomes of those with COVID-19. In addition, concerns regarding the use of statins and an increase in COVID-19 infections have been raised, as statins may increase the expression of angiotensin-converting enzyme 2 (ACE2), the primary receptor for the SARS-CoV-2 virus. Our goal was to investigate the effect of statins in COVID-19 patients in a large, diverse patient population across the United States containing nearly 120,000 patients diagnosed with COVID-19. We used propensity score matching of demographics, comorbidities, and medication indication to compare statin-treated patients (N = 2,297) with matched controls (N = 4,594). We observed a small, but statistically significant, decrease in mortality among patients prescribed statins (16.1%) when compared with matched COVID-19-positive controls (18.0 to 20.6%). These results support previous evidence that statins do not increase COVID-19-related mortality and may, in fact, have a mitigating effect on severity of the disease reflected in a slight reduction in mortality. Mixed findings on effects of statins in COVID-19 patients reported in the literature should prompt prospective randomized controlled trials in order to define better who might be advantaged with respect to clinical outcomes. Frontiers Media S.A. 2021-02-03 /pmc/articles/PMC7887302/ /pubmed/33614688 http://dx.doi.org/10.3389/fmed.2021.639804 Text en Copyright © 2021 Marić, Oskotsky, Kosti, Le, Wong, Shaw, Sirota and Stevenson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Marić, Ivana Oskotsky, Tomiko Kosti, Idit Le, Brian Wong, Ronald J. Shaw, Gary M. Sirota, Marina Stevenson, David K. Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title | Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title_full | Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title_fullStr | Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title_full_unstemmed | Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title_short | Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US |
title_sort | decreased mortality rate among covid-19 patients prescribed statins: data from electronic health records in the us |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887302/ https://www.ncbi.nlm.nih.gov/pubmed/33614688 http://dx.doi.org/10.3389/fmed.2021.639804 |
work_keys_str_mv | AT maricivana decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT oskotskytomiko decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT kostiidit decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT lebrian decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT wongronaldj decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT shawgarym decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT sirotamarina decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus AT stevensondavidk decreasedmortalityrateamongcovid19patientsprescribedstatinsdatafromelectronichealthrecordsintheus |